CD36 and pancreatic neoplasm: Exploration of signaling pathways, both of the TGF-beta dependent and Hedgehog and of the crosstalk with CD36 and CD97, or of these with other intracellular signaling molecules offers potential solutions for stratification of pancreatic cancers and optimization of therapies, based on particular aspects of each subset.